BeyondSpring (BYSI) Revenue & Revenue Breakdown
BeyondSpring Revenue Highlights
Latest Revenue (Y)
$1.75M
Latest Revenue (Q)
$438.00K
BeyondSpring Revenue by Period
BeyondSpring Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.75M | 29.61% |
| 2022-12-31 | $1.35M | - |
| 2021-12-31 | $1.35M | 650.56% |
| 2020-12-31 | $180.00K | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | - |
BeyondSpring generated $1.75M in revenue during NA 2023, up 29.61% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
BeyondSpring Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $438.00K | - |
| 2023-09-30 | $438.00K | 0.11% |
| 2023-06-30 | $437.50K | - |
| 2023-03-31 | $437.50K | 29.63% |
| 2022-12-31 | $337.50K | - |
| 2022-09-30 | $337.50K | -0.15% |
| 2022-06-30 | $338.00K | - |
| 2021-12-31 | $338.00K | 0.30% |
| 2021-09-30 | $337.00K | -0.30% |
| 2021-06-30 | $338.00K | - |
| 2021-03-31 | $338.00K | 87.78% |
| 2020-12-31 | $180.00K | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | - |
BeyondSpring generated $438.00K in revenue during Q4 2023, up 0.00% compared to the previous quarter, and up 129.78% compared to the same period a year ago.
BeyondSpring Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MCRB | Seres Therapeutics | $126.33M | - |
| EYPT | EyePoint Pharmaceuticals | $46.02M | $9.48M |
| OCUP | Ocuphire Pharma | $19.05M | - |
| SCPH | scPharmaceuticals | $13.59M | $6.10M |
| KA | Kineta | $5.44M | - |
| BYSI | BeyondSpring | $1.75M | $438.00K |
| MIST | Milestone Pharmaceuticals | $1.00M | - |
| ADTX | Aditxt | $645.18K | $44.28K |
| LIFE | aTyr Pharma | $353.00K | $235.00K |
| ALVR | AlloVir | - | - |
| FBRX | Forte Biosciences | - | - |
| INKT | MiNK Therapeutics | - | - |
| RVPH | Reviva Pharmaceuticals | - | - |
| ONCY | Oncolytics Biotech | - | - |
| ONCT | Oncternal Therapeutics | - | - |
| CADL | Candel Therapeutics | - | - |
| SLS | SELLAS Life Sciences Group | - | - |
| SRZN | Surrozen | - | - |
| KTTA | Pasithea Therapeutics | - | - |
BYSI Revenue FAQ
What is BeyondSpring’s yearly revenue?
BeyondSpring's yearly revenue for 2023 was $1.75M, representing an increase of 29.61% compared to 2022. The company's yearly revenue for 2022 was $1.35M, representing an increase of 0% compared to 2021. BYSI's yearly revenue for 2021 was $1.35M, representing an increase of 650.56% compared to 2020.
What is BeyondSpring’s quarterly revenue?
BeyondSpring's quarterly revenue for Q4 2023 was $438K, a 0% increase from the previous quarter (Q3 2023), and a 29.78% increase year-over-year (Q4 2022). The company's quarterly revenue for Q3 2023 was $438K, a 0.11% increase from the previous quarter (Q2 2023), and a 29.78% increase year-over-year (Q3 2022). BYSI's quarterly revenue for Q2 2023 was $437.5K, a 0% increase from the previous quarter (Q1 2023), and a 29.44% increase year-over-year (Q2 2022).
What is BeyondSpring’s revenue growth rate?
BeyondSpring's revenue growth rate for the last 3 years (2021-2023) was 29.61%, and for the last 5 years (2019-2023) was 0%.